Country: Malta
Language: English
Source: Medicines Authority
PERINDOPRIL TERT, BUTYLAMINE SALT, INDAPAMIDE
Sandoz Pharmaceuticals d.d. Verovškova Ulica 57, SI-1000 Ljubljana, Slovenia
C09BA04
PERINDOPRIL TERT-BUTYLAMINE SALT 4 mg INDAPAMIDE 1.25 mg
TABLET
PERINDOPRIL TERT-BUTYLAMINE SALT 4 mg INDAPAMIDE 1.25 mg
POM
AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
Withdrawn
2010-07-21
PACKAGE LEAFLET: INFORMATION FOR THE USER PACKAGE LEAFLET: INFORMATION FOR THE USER PACKAGE LEAFLET: INFORMATION FOR THE USER PACKAGE LEAFLET: INFORMATION FOR THE USER Perindopril/Indapamide 4 mg / 1.25mg tablets _ _ _Perindopril tert-butylamine/indapamide _ Read all of this leaflet carefully before you start taking this medicine. Read all of this leaflet carefully before you start taking this medicine. Read all of this leaflet carefully before you start taking this medicine. Read all of this leaflet carefully before you start taking this medicine. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. • If any of the side effects gets serious, or if you notice any side effect not listed in this leaflet, please tell your doctor or pharmacist. In this leaflet: In this leaflet: In this leaflet: In this leaflet: 1. What Perindopril/Indapamide it is and what is used for 2. Before you take Perindopril/Indapamide 3. How to take Perindopril/Indapamide 4. Possible side effects 5. How to store Perindopril/Indapamide 6. Further information 1. WHAT IS AND WHAT IT IS USED FOR 1. WHAT IS AND WHAT IT IS USED FOR 1. WHAT IS AND WHAT IT IS USED FOR 1. WHAT IS AND WHAT IT IS USED FOR Perindopril/Indapamide Perindopril/Indapamide Perindopril/Indapamide Perindopril/Indapamide Perindopril/Indapamide tablets are a combination of two active ingredients, perindopril and indapamide. This medicine is used in the treatment of high blood is used in the treatment of high blood is used in the tr Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Perindopril/Indapamide 4 mg / 1.25 mg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 4.00 mg of perindopril tert-butylamine, equivalent to 3.338 mg perindopril, and 1.25 mg of indapamide. Excipient(s): lactose monohydrate. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablet. white, oblong, biconvex tablet debossed with PI on one side 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of essential hypertension; Perindopril/Indapamide 4 mg / 1.25 mg tablets is indicated in patients whose blood pressure is not adequately controlled on perindopril alone. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Oral route. One Perindopril/Indapamide 4 mg / 1.25 mg tablet per day as a single dose, preferably to be taken in the morning, and before a meal. When possible individual dose titration with the components is recommended. Perindopril/Indapamide 4 mg / 1.25 mg tablets should be used when blood pressure is not adequately controlled on Perindopril/Indapamide 2mg/0.625mg tablets (where available). When clinically appropriate, direct change from monotherapy to perindopril/indapamide combination may be considered. _Elderly (see section 4.4)_ Treatment should be initiated after considering blood pressure response and renal function. _Patients with renal impairment_ _(see section 4.4)._ In severe renal impairment (creatinine clearance below 30 ml/min), treatment is contraindicated. Page 2 of 18 In patients with moderate renal impairment (creatinine clearance 30–60 ml/min), it is recommended to start treatment with the adequate dosag Read the complete document